Cleared Traditional

K173916 - Finapres Nova Noninvasive Hemodynamic Monitor

K173916 is an FDA 510(k) clearance for Finapres Nova Noninvasive Hemodynamic M..., manufactured by Finapres Medical Systems B.V.. The device is a Class 2 Cardiovascular device with product code DXN cleared through the Traditional 510(k) pathway after a 319-day FDA review.

K173916 · Finapres Medical Systems B.V. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2018
Decision
319d
Days
Class 2
Risk

K173916 is an FDA 510(k) clearance for the Finapres Nova Noninvasive Hemodynamic Monitor. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Finapres Medical Systems B.V. (Enschede, NL). The FDA issued a Cleared decision on November 6, 2018 after a review of 319 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Finapres Medical Systems B.V. devices

FDA 510(k) Submission Details - K173916

510(k) Number K173916 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 22, 2017
Decision Date November 06, 2018
Days to Decision 319 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
194d slower than avg
Panel avg: 125d · This submission: 319d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXN Device Classification - Class 2, Special Controls

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 844
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K173916.
EV1000 Clinical Platform Non-Invasive (NI) with ClearSight Finger Cuffs or ClearSight System
K182245 · Edwards Lifesciences, LLC · Nov 2018
HEM-6410T-ZM Wrist Blood Pressure Monitor
K182481 · Omron Healthcare, Inc. · Nov 2018
Wrist Blood Pressure Monitor Model BP4350
K182166 · Omron Healthcare, Inc. · Nov 2018
Wrist Blood Pressure Monitor Model BP6100
K182127 · Omron Healthcare, Inc. · Nov 2018
Full Automatic(NIBP) Blood Pressure Monitor
K180240 · Health & Life Co., Ltd. · Oct 2018
Bluetooth blood pressure monitor
K182018 · Shenzhen Kingyield Technology Co., Ltd. · Oct 2018